Evidence map›Paper›PMID 37384309›Full record

ArticleFrontiers in pediatrics2023

Beyond the known phenotype of sotos syndrome: a 31-individuals cohort study.

Vega-Hanna Lourdes, Sanz-Cuesta Mario, Casas-Alba Didac, Bolasell Mercè, Martorell Loreto, Pías Leticia, Feller Ana Lucia, Antonio Federico Martínez-Monseny, Serrano Mercedes

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  5. Observational
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Vega-Hanna LourdesDepartment of Pediatrics, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Sanz-Cuesta MarioDepartment of Pediatrics, Hospital de Sant Boi, Parc Sanitari Sant Joan de Déu, Barcelona, Spain.
Casas-Alba DidacDepartment of Genetic and Molecular Medicine/IPER, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Bolasell MercèDepartment of Genetic and Molecular Medicine/IPER, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Martorell LoretoDepartment of Genetic and Molecular Medicine/IPER, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Pías LeticiaDepartment of Genetic and Molecular Medicine/IPER, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Feller Ana LuciaDepartamen of Pediatrics, Hospital J P Garrahan, Buenos Aires, Argentine.
Antonio Federico Martínez-MonsenyDepartment of Genetic and Molecular Medicine/IPER, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Serrano MercedesPediatric Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu, Barcelona, Spain.
Hospital Sant Joan de Déu Barcelona · ESGarrahan Hospital · ARInstituto de Salud Carlos III · ESParc Sanitari Sant Joan de Déu · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sotos Syndrome (SS, OMIM#117550) is a heterogeneous genetic condition, recognized by three main clinical features present in most cases: overgrowth with macrocephaly, typical facial appearance and different degrees of intellectual disability. Three different types are described caused by variants or deletions/duplications in Methods: In our referral center, we collected and analyzed clinical and genetic data of 31-patients cohort diagnosed with SS. Results: All of them presented with overgrowth, typical dysmorphic features and different degree of developmental delay. Although structural cardiac defects have been reported in SS, non-structural diseases such as pericarditis were outstanding in our cohort. Moreover, we described here novel oncological malignancies not previously linked to SS such as splenic hamartoma, retinal melanocytoma and acute lymphocytic leukemia. Finally, five patients suffered from recurrent onychocryptosis that required surgical procedures, as an unreported prevalent medical condition. Discussion: This is the first study focusing on multiple atypical symptoms in SS at the time that revisits the spectrum of clinical and molecular basis of this heterogeneous entity trying to unravel a genotype-phenotype correlation.

Indexed as

APC2NFIXNSD1overgrowthphenotypesotos syndrome

Identifiers

PMID37384309
PMCPMC10298147
OpenAlexW4380629755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.